Journal of Preventive Medicine and Public Health

The Korean Society for Preventive Medicine (대한예방의학회)
권호 표지

Costs of Initial Cancer Care and its Affecting Factors

암 환자의 발생 초기 의료비와 이에 영향을 미치는 요인

  • Kim, So-Young (Division of Cardiovascular & Rare Diseases, Korean Centers for Disease Control and Prevention) ;
  • Kim, Sung-Gyeong (National Cancer Control Research Institute, National Cancer Center) ;
  • Park, Jong-Hyock (National Cancer Control Research Institute, National Cancer Center) ;
  • Park, Eun-Cheol (National Cancer Control Research Institute, National Cancer Center)
  • 김소영 (질병관리본부 심혈관희귀질환팀) ;
  • 김성경 (국립암센터 국가암관리사업단) ;
  • 박종혁 (국립암센터 국가암관리사업단) ;
  • 박은철 (국립암센터 국가암관리사업단)
  • Published : 2009.07.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives : The purposes of this study is to estimate the cost of cancer care after its diagnosis and to identify factors that can influence the cost of cancer care. Methods : The study subjects were patients with an initial diagnosis one of four selected tumors and had their first two-years of cancer care at a national cancer center. The data were obtained from medical records and patient surveys. We classified cancer care costs into medical and nonmedical costs, and each cost was analyzed for burden type, medical service, and cancer stage according to cancer types. Factors affecting cancer care costs for the initial phase included demographic variables, socioeconomic status and clinical variables. Results : Cancer care costs for the initial year following diagnosis were higher than the costs for the following successive year after diagnosis. Lung cancer (25,648,000 won) had higher costs than the other three cancer types. Of the total costs, patent burden was more than 50% and medical costs accounted for more than 60%. Inpatient costs accounted for more than 60% of the medical costs for stomach and liver cancer in the initial phase. Care for latestage cancer was more expensive than care for early-stage cancer. Nonmedical costs were estimated to be between 4,500,000 to 6,000,000 won with expenses for the caregiver being the highest. The factors affecting cancer care costs were treatment type and cancer stage. Conclusions : The cancer care costs after diagnosis are substantial and vary by cancer site, cancer stage and treatment type. It is useful for policy makers and researchers to identify tumor-specific medical and nonmedical costs. The effort to reduce cancer costs and early detection for cancer can reduce the burden to society and improve quality of life for the cancer patients.

Keywords

References

  1. Wilking N, Jonsson B. The burden and cost of cancer. Ann Oncol 2007; 18(suppl 3): iii8-iii22 https://doi.org/10.1093/annonc/mdm097
  2. Yabroff KR, Warren JL, Brown ML. Costs of cancer care in the USA: A descriptive review. Nat Clin Pract Oncol 2007; 4(11): 643-656 https://doi.org/10.1038/ncponc0978
  3. Meropol NJ, Schulman KA. Cost of cancer care: Issues and implications. J Clin Oncol 2007; 25(2): 180-186 https://doi.org/10.1200/JCO.2006.09.6081
  4. Wapner J. Bills of health: In discussing treatments, cancer doctors plan to include cost. Sci Am 2008; 299(2): 28 https://doi.org/10.1038/scientificamerican0808-28
  5. Korea National Statistical Office. Annual Report on the Cause of Death Statistics. Daejron: Korea National Statistical Offic; 2007. (Korean)
  6. National Cancer Center; Ministry for Health; Welfare and Family Affairs. Cancer Facts & Figures 2008. Goyang: National Cancer Center; 2008. (Korean)
  7. Yabroff KR, Mariotto AB, Feuer E, Brown M. Projections of the costs associated with colorectal cancer care in the US, 2000-2020. Health Econ 2008; 17(8): 947-959 https://doi.org/10.1002/hec.1307
  8. Warren JL, Yabroff KR, Meekins A, Topor M, Lamont EB, Brown ML. Evaluation of trends in the cost of initial cancer treatment. J Natl Cancer Inst 2008; 100(12): 888-897 https://doi.org/10.1093/jnci/djn175
  9. Yabroff KR, Lamont EB, Mariotto A, Warren JL, Topor M, Meekins A, et al. Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst 2008; 100(9): 630-641 https://doi.org/10.1093/jnci/djn103
  10. Lang K, Lines LM, Lee DW, Korn JR, Earle CC, Menzin J. Lifetime and treatment-phase costs associated with colorectal cancer: Evidence from SEER-medicare data. Clin Gastroenterol Hepatol 2009; 7(2): 198-204 https://doi.org/10.1016/j.cgh.2008.08.034
  11. Brown ML, Riley GF, Schussler N, Etzioni R. Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care 2002; 40(8 Suppl): IV-104-117
  12. Kim SG, Park WS. Out-of-pocket health expenditures among adults Koreans with cancer. Korean J Med 2006; 70(1): 61-68. (Korean)
  13. Yi JJ, Yoo WK, Kim SY, Kim KK, Yi SW. Medical expenses by site of cancer and survival time among cancer patients in the last one year of life. J Prev Med Public Health 2005; 38(1): 9-15. (Korean)
  14. Choi KS, Park EC, Lim MK, Lim JH, Kim SG, Park JH, et al. Cost of colorectal cancer care in Korea: A prospective group study with a 2-year follow-up. J Korean Soc Coloproctol 2008; 24(5): 357-366 https://doi.org/10.3393/jksc.2008.24.5.357
  15. Reeder CE, Gordon D. Managing oncology costs. Am J Manag Care 2006; 12(1 Suppl): S3-S16
  16. Yabroff KR, Davis WW, Lamont EB, Fahey A, Topor M, Brown ML, et al. Patient time costs associated with cancer care. J Natl Cancer Inst 2007; 99(1): 14-23 https://doi.org/10.1093/jnci/djk001
  17. Fireman BH, Quesenberry CP, Somkin CP, Jacobson AS, Baer D, West D, et al. Cost of care for cancer in a health maintenance organization. Health Care Financ Rev 1997; 18(4): 51-76
  18. Taplin SH, Barlow W, Urban N, Mandelson MT, Timlin DJ, Ichikawa L, et al. Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst 1995; 87(6): 417-426 https://doi.org/10.1093/jnci/87.6.417
  19. Warren JL, Brown ML, Fay MP, Schussler N, Potosky AL, Riley GF. Costs of treatment for elderly women with early-stage breast cancer in fee-for service settings. J Clin Oncol 2002; 20(1): 307-316 https://doi.org/10.1200/JCO.20.1.307
  20. Langa KM, Fendrick AM, Chernew ME, Kabeto MU, Paisley KL, Hayman JA. Out of pocket healthcare expenditures among older Americans with cancer. Value Health 2004; 7(2): 186-194 https://doi.org/10.1111/j.1524-4733.2004.72334.x
  21. Oliver E, Killen J, Kiebert G, Hutton J, Hall R, Higgins B, et al. Treatment pathways, resource use and costs in the management of small cell lung cancer. Thorax 2001; 56(10): 785-790 https://doi.org/10.1136/thorax.56.10.785
  22. Penberthy L, Retchin SM, McDonald MK, McClish DK, Desch CE, Riley GF, et al. Predictors of medicare costs in elderly beneficiaries with breast, colorectal, lung, or prostate cancer. Health Care Manag Sci 1999; 2(3): 149-160 https://doi.org/10.1023/A:1019096030306
  23. Kim SG, Yu SH, Park WS, Chung WJ. Outof-pocket health expenditures by non-elderly and elderly persons in Korea. J Prev Med Public Health 2005; 38(4): 408-414. (Korean)
  24. Chang S, Long SR, Kutikova L, Bowman L, Finley D, Crown WH, et al. Estimating the cost of cancer: Results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000. J Clin Oncol 2004; 22(17): 3524-3530 https://doi.org/10.1200/JCO.2004.10.170
  25. Bosanquet N, Sikora K. The economics of cancer care in the UK. Lancet Oncol 2004; 5(9): 568-574 https://doi.org/10.1016/S1470-2045(04)01569-4
  26. Ries LA, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, et al. SEER Cancer Statistics Review, 1975-2005. Behesda: National Cancer Institute; 2007
  27. Wagner L, Lacey MD. The hidden costs of cancer care: An overview with implications and referral resources for oncology nurses. Clin J Oncol Nurs 2004; 8(3): 279-287 https://doi.org/10.1188/04.CJON.279-287
  28. Ministry for Health, Welfare and Family Affairs. White Paper on Health, Welfare and Family Affirs. Seoul: Ministry for Health, Welfare; 2007. (Korean)
  29. Chirikos TN. Cancer economics: On variations in the costs of treating cancer. Cancer Control 2002; 9(1): 59-66
  30. Levinsky NG, Yu W, Ash A, Moskowitz M, Gazelle G, Saynina O, et al. Influence fo age on medicare expenditures and medical care in the last of life. JAMA 2001; 286(11): 1349-1355 https://doi.org/10.1001/jama.286.11.1349
  31. Drummond MF, Sculpher MJ, Torrance GW, O Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes. 3nd ed. New York: Oxford University Press; 2005
  32. American Cancer Society. Cancer Facts and Figure 2008. Atalanta: American Cancer Society; 2008
  33. Kim SG, Hahm MI, Choi KS, Seung NY, Shin HR, Park EC. The economic burden of cancer in Korea in 2002. Eur J Cancer Care (Engl) 2008; 17(2): 136-144 https://doi.org/10.1111/j.1365-2354.2007.00818.x